Effect of Sufentanil and Midazolam for reduction of Myoclonic movements
Phase 2
- Conditions
- Myoclonic movements.Drug-induced myoclonus
- Registration Number
- IRCT201307164780N2
- Lead Sponsor
- Research vice chancellor of Mashhad University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion criterion: adult patients ASA??-??? who candidate for elective surgery. Exclusion criteria: patients with impaired adrenal function; sensitivity to drugs; mental disorders, neuromuscular disorders; seizures; and electrolyte abnormalities.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Myoclonus severity. Timepoint: At the end of the study. Method of measurement: According to Myoclonus Rating Scale into mild, moderate and sever.
- Secondary Outcome Measures
Name Time Method